학술논문

Ipragliflozin, a SGLT2 Inhibitor, Reduced Body Weight and Fat Mass but Not Muscle Mass in Japanese Type 2 Diabetic Patients Treated with Insulin-A Randomized Clinical Trial
Document Type
Journal
Source
DIABETES; JUL 1 2018, 67 3p. Supplement: 1
Subject
Language
English
ISSN
1939327X